Literature DB >> 23829106

Not lost in translation: how study of diseases in our pets can benefit them and us.

Carolyn J Henry1, Jeffrey N Bryan.   

Abstract

Practice-changing medical discovery requires preclinical and clinical assessment be carried out using appropriate disease models. There is growing awareness of companion animals with naturally-occurring disease as such models. They offer significant advantages over more traditional in vivo models of induced disease. This review describes current efforts to promote translation of discoveries between human and veterinary medicine in order to more rapidly and efficiently make progress in improving the health of all human and animal patients.

Entities:  

Mesh:

Year:  2013        PMID: 23829106      PMCID: PMC6179846     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  11 in total

1.  Franklin H. Epstein Lecture. Both ends of the leash--the human links to good dogs with bad genes.

Authors:  Elaine A Ostrander
Journal:  N Engl J Med       Date:  2012-08-16       Impact factor: 91.245

2.  Clinical trials going to the dogs: canine program to study tumor treatment, biology.

Authors:  George S Mack
Journal:  J Natl Cancer Inst       Date:  2006-02-01       Impact factor: 13.506

3.  Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.

Authors:  Gregory M Acland; Gustavo D Aguirre; Jean Bennett; Tomas S Aleman; Artur V Cideciyan; Jeannette Bennicelli; Nadine S Dejneka; Susan E Pearce-Kelling; Albert M Maguire; Krzysztof Palczewski; William W Hauswirth; Samuel G Jacobson
Journal:  Mol Ther       Date:  2005-10-14       Impact factor: 11.454

Review 4.  Of dogs and men: comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma.

Authors:  Kenneth S Rankin; Mike Starkey; John Lunec; Craig H Gerrand; Sue Murphy; Swethajit Biswas
Journal:  Pediatr Blood Cancer       Date:  2011-10-11       Impact factor: 3.167

Review 5.  Translation of new cancer treatments from pet dogs to humans.

Authors:  Melissa Paoloni; Chand Khanna
Journal:  Nat Rev Cancer       Date:  2008-02       Impact factor: 60.716

6.  Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis.

Authors:  Tomoyuki Awano; Gary S Johnson; Claire M Wade; Martin L Katz; Gayle C Johnson; Jeremy F Taylor; Michele Perloski; Tara Biagi; Izabella Baranowska; Sam Long; Philip A March; Natasha J Olby; G Diane Shelton; Shahnawaz Khan; Dennis P O'Brien; Kerstin Lindblad-Toh; Joan R Coates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

Review 7.  Comparative aspects of osteosarcoma. Dog versus man.

Authors:  S J Withrow; B E Powers; R C Straw; R M Wilkins
Journal:  Clin Orthop Relat Res       Date:  1991-09       Impact factor: 4.176

8.  Leber congenital amaurosis: from darkness to spotlight.

Authors:  Josseline Kaplan
Journal:  Ophthalmic Genet       Date:  2008-09       Impact factor: 1.803

9.  A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog.

Authors:  Frode Lingaas; Kenine E Comstock; Ewen F Kirkness; Anita Sørensen; Tone Aarskaug; Christophe Hitte; Michael L Nickerson; Lars Moe; Laura S Schmidt; Rachael Thomas; Matthew Breen; Francis Galibert; Berton Zbar; Elaine A Ostrander
Journal:  Hum Mol Genet       Date:  2003-10-07       Impact factor: 6.150

10.  Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.

Authors:  Melissa C Paoloni; Anita Tandle; Christina Mazcko; Engy Hanna; Stefan Kachala; Amy Leblanc; Shelley Newman; David Vail; Carolyn Henry; Douglas Thamm; Karin Sorenmo; Amin Hajitou; Renata Pasqualini; Wadih Arap; Chand Khanna; Steven K Libutti
Journal:  PLoS One       Date:  2009-03-30       Impact factor: 3.240

View more
  6 in total

Review 1.  Fetal Microchimerism in Cancer Protection and Promotion: Current Understanding in Dogs and the Implications for Human Health.

Authors:  Jeffrey N Bryan
Journal:  AAPS J       Date:  2015-02-19       Impact factor: 4.009

2.  The health effects of fetal microchimerism can be modeled in companion dogs.

Authors:  Senthil R Kumar; Sarah A Hansen; Sandra M Axiak-Bechtel; Jeffrey N Bryan
Journal:  Chimerism       Date:  2013-09-30

3.  The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine.

Authors:  Saurabh Jain; Luca Aresu; Stefano Comazzi; Jianguo Shi; Erin Worrall; John Clayton; William Humphries; Sandra Hemmington; Paul Davis; Euan Murray; Asmare A Limeneh; Kathryn Ball; Eva Ruckova; Petr Muller; Borek Vojtesek; Robin Fahraeus; David Argyle; Ted R Hupp
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

4.  The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma.

Authors:  Joana N R Dias; Sandra I Aguiar; Diane M Pereira; Ana S André; Lurdes Gano; João D G Correia; Belmira Carrapiço; Barbara Rütgen; Rui Malhó; Conceição Peleteiro; João Goncalves; Cecília M P Rodrigues; Solange Gil; Luís Tavares; Frederico Aires-da-Silva
Journal:  Oncotarget       Date:  2018-06-19

5.  Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies.

Authors:  Joana N R Dias; Ana S André; Sandra I Aguiar; Joana Ministro; Joana Oliveira; Maria C Peleteiro; Barbara Rütgen; Lurdes Gano; João D G Correia; Soraia S Oliveira; Joao Goncalves; Solange Gil; Luís Tavares; Frederico Aires-da-Silva
Journal:  PLoS One       Date:  2018-12-28       Impact factor: 3.240

Review 6.  The One Medicine concept: its emergence from history as a systematic approach to re-integrate human and veterinary medicine.

Authors:  Tracey A King
Journal:  Emerg Top Life Sci       Date:  2021-11-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.